Uncategorized

The company cited Just-Bomholt’s strategic leadership, international experience and ability to drive profitable growth and global expansion as evidence he is the right person for the job.

Robert F. Kennedy Jr.’s removal of all remaining members of the CDC’s Advisory Committee on Immunization Practices raises questions about the upcoming meeting later this month. Analysts fear the committee could be more sympathetic to the HHS Secretary’s anti-vax viewpoints.

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused five clinical trials. Gilead also stressed that the hold does not impact any other assets in its HIV pipeline.

Odyssey filed for an IPO in January but never revealed a fundraising target.

Medtronic had planned to spin out the two units before consolidating them into one segment last year.

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027.

The reinstatement of the generic drug policy office is the latest reversal of course for Robert F. Kennedy Jr.’s HHS, which also recently rehired FDA staff responsible for making travel arrangements and those involved in user fee program negotiations.

Merck’s Enflonsia will go up against Sanofi and AstraZeneca’s Beyfortus, which the partners plan to ship out early in the third quarter.

En un nuevo estudio, se ha explorado la influencia de los rasgos de personalidad en el desarrollo y la perpetuación del insomnio.   El estudio lo ha realizado un equipo de la Facultad de Medicina de la Universidad de Sao Paulo (USP), en Brasil.   “Decidimos estudiar la inf …

El síndrome de Marfan es una enfermedad rara sin cura actualmente y que afecta a un porcentaje minúsculo de la población. En el caso de la Unión Europea, solo 7 de cada 100.000 personas lo padecen.   Se trata de una enfermedad genética del tejido conectivo q …